Piramal Healthcare Ltd

• 

  Piramal Eyes Nutrition, Cough-Cold Brands to Boost Consumer Health Arm

  Piramal Enterprises Ltd is exploring buying nutritional supplements and cough and cold brands to grow its consumer healthcare business to among the three largest in the country by 2020, a senior executive said.

• Abbott India Posts 71 Per Cent Rise in Q1 Profit; Shares Rise

  Shares in Abbott India Ltd rose as much as 13 per cent on Thursday as the drug firm posted a 71.42 per cent rise in net profit at Rs 50.93 crore for the quarter ended June 2014.

• Slow drug test approvals put industry at risk

  Slower government approval for testing new medicines is threatening India's aspirations to be a fast-growing, low-cost hub for clinical trials, and has prompted some drug firms to shift operations elsewhere, adding to their costs.

• Piramal Health posts Rs 38.68 cr quarterly loss

  Total income of the company stood at Rs 688.07 crore for the quarter ended March 31, 2012. It was Rs 689.29 crore for the same quarter of 2011.

• Abbott, Biocon to develop nutrition products for India

  Abbott Laboratories has partnered India's Biocon Ltd to develop nutrition products for India.

• Piramal Healthcare to change name to Piramal Enterprises

  Piramal Healthcare said that its board has approved to change its name to Piramal Enterprises Ltd.

• Piramal Healthcare Ltd - Fixes Book Closure for Dividend & AGM

  Piramal Healthcare Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 01, 2011 to August 09, 2011 (both days inclusive) for the purpose of Payment of Dividend & 64th Annual General Meeting (AGM) of the Company to be held on August 09, 2011.

• Piramal Healthcare Ltd - Board recommends Normal & One-time Special Dividend

  Piramal Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 06, 2011, inter alia, has taken the following decision: 1. The Board has recommended dividend of Rs. 6 per equity share of face value of Rs. 2/- (i.e. @ 300%) for the financial year ended March 31, 2011. 2. In addition to this, the Board ha...

• Piramal Healthcare Ltd - Outcome of Board Meeting

  Piramal Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 06, 2011, inter alia, has taken the following decisions : 1. The Board has for some time, been deliberating on new business opportunities. One of the business opportunities which were being explored in this regard was in the area of Financi...

• Piramal Life Sciences Ltd - Piramal Life Sciences Limited and Piramal Healthcare Limited- Demerger of the NCE Research Unit of Piramal Life Sciences L

  Piramal Life Sciences Ltd has informed BSE regarding a Press Release dated May 06, 2011 titled "Piramal Life Sciences Limited and Piramal Healthcare Limited- Demerger of the NCE Research Unit of Piramal Life Sciences Limited into Piramal Healthcare Limited"

• Piramal Healthcare Ltd - Announces Consolidated Q4 & FY11 results

  Piramal Healthcare Ltd has announced the following Consolidated results for the quarter & year ended March 31, 2011 The Unaudited consolidated results for the Quarter ended March 31, 2011 The Group has posted a net profit of Rs 2018.50 million for the quarter ended March 31, 2011 where as the same was at Rs 1543.20 million for the quarter ended...

• Piramal Healthcare Ltd - Announces Standalone Q4 & FY11 results

  Piramal Healthcare Ltd has announced the following Standalone results for the quarter & year ended March 31, 2011: The Unaudited results for the Quarter ended March 31, 2011 The Company has posted a net profit of Rs 1680.00 million for the quarter ended March 31, 2011 where as the same was at Rs 1166.10 million for the quarter ended March 31, 2...

• Piramal Healthcare Ltd - Updates on Buy Back

  With reference to the earlier announcement dated December 09, 2010 regarding Buy Back, Piramal Healthcare Ltd has now informed that the letter of Offer for the Buyback is in the process of finalisation and shall be dispatched once the Company have received the necessary regulatory clearances. Consequently, the Company will issue a Corrigendum to th...

• Piramal Healthcare Ltd - Buy Back through tender Offer

  Kotak Mahindra Capital Company Ltd ("Manager to the Buyback") on behalf of Piramal Healthcare Ltd ("Target Company") has issued this the Public Announcement to the Shareholders / Beneficial Owners of the equity shares of the Target Company, pursuant to and in accordance with the Securities and Exchange Board of India (Buy-Back of Se...

• Piramal Healthcare Ltd - Result of Postal Ballot

  Piramal Healthcare Ltd has informed BSE that the members of the Company, by way of Postal Ballot, have passed the following resolutions, by overwhelming requisite majority:  1. Accorded for the buyback by the Company of its equity shares of face value Rs. 2 each not exceeding 4,18,02,629 equity shares of the Company, at a price of Rs. 600 per ...